Please login to the form below

Not currently logged in
Email:
Password:

rebrand

This page shows the latest rebrand news and features for those working in and with pharma, biotech and healthcare.

Avenir acquires Cherry, EY wins new account and GK unites businesses

Avenir acquires Cherry, EY wins new account and GK unites businesses

The move comes as the consultancy celebrates 10 years, and the business has undergone a full rebrand, which the company says represents its status as a dynamic, youthful disrupter.

Latest news

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Rebranding in an evolving world Rebranding in an evolving world

    upon. A shift in culture. Our rebrand undeniably infiltrated all aspects of our company, not least our company values, vision and people. ... Since the rebrand, I am proud to say that, to date, we have set out exactly what we wanted to achieve.

  • When is it time to rebrand? When is it time to rebrand?

    But at some point, that is not enough. Leaders need to recognise when it is time to rebrand - time to activate a new customer experience - and time to reaffirm mission and

  • Building the Future Building the Future

    Firms that simply restructure and rebrand miss their opportunity and fail to adapt successfully to our changing market.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics